tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:640 Stock Latest News

CR Sanjiu Posts Strong Asset and Revenue Growth, Boosts Dividend for 2025
Company AnnouncementsCR Sanjiu Posts Strong Asset and Revenue Growth, Boosts Dividend for 2025
2d ago
CR Boya Revenue Rises but Profit Slumps as China Resources Pharma Unit Proposes Dividend
PremiumCompany Announcements
CR Boya Revenue Rises but Profit Slumps as China Resources Pharma Unit Proposes Dividend
2d ago
China Resources Pharma Subsidiary Dong-E-E-Jiao Lifts 2025 Profit and Proposes Higher Dividend
PremiumCompany Announcements
China Resources Pharma Subsidiary Dong-E-E-Jiao Lifts 2025 Profit and Proposes Higher Dividend
3d ago
China Resources Pharma Subsidiary KPC Posts Profit Slump but Maintains Dividend
PremiumCompany Announcements
China Resources Pharma Subsidiary KPC Posts Profit Slump but Maintains Dividend
3d ago
CR Double-Crane Grows Profit and Net Assets Despite Flat 2025 Revenue
PremiumCompany Announcements
CR Double-Crane Grows Profit and Net Assets Despite Flat 2025 Revenue
3d ago
CR Jiangzhong Lifts Profit and Dividend Despite Revenue Dip in 2025
PremiumCompany AnnouncementsCR Jiangzhong Lifts Profit and Dividend Despite Revenue Dip in 2025
3d ago
China Resources Pharmaceutical Plans Further Stake Sale in Tianmai Biotechnology
Premium
Company Announcements
China Resources Pharmaceutical Plans Further Stake Sale in Tianmai Biotechnology
6d ago
China Resources Pharmaceutical Sets March Board Meeting on 2025 Results, Dividend Plan
Premium
Company Announcements
China Resources Pharmaceutical Sets March Board Meeting on 2025 Results, Dividend Plan
16d ago
China Resources Pharma Unit to Invest RMB1.5 Billion in New Health Consumer Products Park
PremiumCompany Announcements
China Resources Pharma Unit to Invest RMB1.5 Billion in New Health Consumer Products Park
1M ago
China Resources Pharma Launches RMB1.42 Billion Tender to Sell Tianmai Biotechnology Stake
PremiumCompany Announcements
China Resources Pharma Launches RMB1.42 Billion Tender to Sell Tianmai Biotechnology Stake
1M ago
China Resources Pharmaceutical Shareholders Approve Sales Framework and New Articles at 2026 EGM
PremiumCompany Announcements
China Resources Pharmaceutical Shareholders Approve Sales Framework and New Articles at 2026 EGM
1M ago
CR Sanjiu Posts Double-Digit Revenue Growth but Softer Profit Gains in 2025
PremiumCompany Announcements
CR Sanjiu Posts Double-Digit Revenue Growth but Softer Profit Gains in 2025
1M ago
Tasly Pharmaceutical Posts Higher 2025 Profit Despite Revenue Dip and Reliance on One-Off Gains
PremiumCompany AnnouncementsTasly Pharmaceutical Posts Higher 2025 Profit Despite Revenue Dip and Reliance on One-Off Gains
1M ago
Subsidiary KPC Pharmaceuticals Warns of Sharp Profit Decline in 2025 Unaudited Results
Premium
Company Announcements
Subsidiary KPC Pharmaceuticals Warns of Sharp Profit Decline in 2025 Unaudited Results
1M ago
CR Boya Warns of Profit Slump Despite Revenue Growth After Green Cross Acquisition
Premium
Company Announcements
CR Boya Warns of Profit Slump Despite Revenue Growth After Green Cross Acquisition
2M ago
China Resources Pharma Subsidiary Wins CSRC Nod for RMB3 Billion Bond Programme
PremiumCompany Announcements
China Resources Pharma Subsidiary Wins CSRC Nod for RMB3 Billion Bond Programme
2M ago
China Resources Jiangzhong Pharmaceutical Lifts 2025 Profit Despite Revenue Decline
PremiumCompany Announcements
China Resources Jiangzhong Pharmaceutical Lifts 2025 Profit Despite Revenue Decline
2M ago
China Resources Pharmaceutical Calls 2026 EGM to Approve Sales Framework and New Articles
PremiumCompany Announcements
China Resources Pharmaceutical Calls 2026 EGM to Approve Sales Framework and New Articles
2M ago
China Resources Pharmaceutical Pushes Back Date for Sales Framework Circular
PremiumCompany Announcements
China Resources Pharmaceutical Pushes Back Date for Sales Framework Circular
2M ago
China Resources Pharmaceutical Delays Circular on 2026–2028 Sales Framework Agreement
PremiumCompany AnnouncementsChina Resources Pharmaceutical Delays Circular on 2026–2028 Sales Framework Agreement
2M ago
China Resources Pharma Renews Connected Energy Supply Deal for Southern China Plant
Premium
Company Announcements
China Resources Pharma Renews Connected Energy Supply Deal for Southern China Plant
3M ago
China Resources Pharmaceutical Finalises Setup of Biotech-Focused Investment Fund
Premium
Company Announcements
China Resources Pharmaceutical Finalises Setup of Biotech-Focused Investment Fund
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >